Table 4.
Life Span Study |
INWORKS |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Dose coefficient at 1 Gy | 90% Cl | Deviance | df | P1df | Dose coefficient at 1 Gy | 90% Cl | Deviance | df | P1df | |
ERR modela | ||||||||||
ERR(d) = β1d | 12,404.9 | 29,058 | 5541.4 | 11,006 | ||||||
β1: linear | 0.28 | 0.18; 0.38 | 0.29 | 0.07; 0.53 | ||||||
ERR(d) = β1d + β2d2 | 12,404.6 | 29,057 | 0.548c | 5541.3 | 11,005 | 0.909c | ||||
β1: linear | 0.23 | 0.10; 0.40 | 0.27 | −0.14; 0.68 | ||||||
β2: quadratic | 0.03 | −0.05; 0.10 | 0.06 | −0.78; 1.04 | ||||||
ERR(d,a) = β1d exp(υa) | 12,401.1 | 29,056 | 0.147d | 5,539.0 | 11,004 | 0.307d | ||||
ERR/Gy at attained age < 60 years | 0.35 | 0.19; 0.57 | 0.35 | −0.26; 1.04 | ||||||
ERR/Gy at attained age 60– < 80 years | 0.31 | 0.20; 0.43 | 0.19 | −0.05; 0.46 | ||||||
ERR/Gy at attained age 80+ years | 0.16 | 0.06; 0.29 | 0.86 | 0.20; 1.61 | ||||||
EAR modelb | ||||||||||
EAR(d) = β1d | 12,831.6 | 29,395 | 6329.2 | 11,848 | ||||||
β1: linear | 8.03 | 3.74; 13.07 | 1.68 | < 0; 7.55 | ||||||
EAR(d,a) = β1d exp(υa) | 12,812.4 | 29,393 | < 0.001d | 6322.1 | 11,846 | 0.029d | ||||
EAR/Gy at attained age < 60 years | 5.84 | 3.07; 9.50 | 0.42 | < 0; 6.10 | ||||||
EAR/Gy at attained age 60– < 80 years | 20.79 | 11.56; 31.55 | 13.86 | −4.34; 33.16 | ||||||
EAR/Gy at attained age 80+ years | 33.27 | 13.85; 60.23 | 190.40 | 58.67; 334.9 |
CI likelihood-based confidence interval
Defined as λ0(c,s,b,a)[1 + ERR(d,a)], where d is colon dose (cumulative in INWORKS), c is city for the LSS and country for INWORKS, s is sex, b is birth year, a is attained age in three categories (< 60, 60–80, 80+ years)
Defined as λ0(c,s,b,a) + EAR(d,a), the dose coefficients in the EAR model describe the excess cases per 10,000 person-years per 1 Gy
The LSS ERR and EAR estimates are weighted averages over sex with a weight of 0.88 for males and 0.12 for females
P1df: p value of a likelihood ratio test vs. cβ2 = 0 or dυ = 0
< 0: lower CI bound not estimated (on the boundary of the parameter space)